United States-based Innova Medical Group Inc announced on Monday that it has named Sean Rogers as the chairman of Innova Medical Group and Todd Malan, MD as its new chief medical officer.
Prior to joining Innova Medical Group, Rogers was the global head of Technology Strategy and Solutions. He was also chief executive officer of Pasaca Capital.
Dr Malan was the senior vice president of clinical research at Quantum Material Corporation. He was previously the chief medical officer for iQuantum Labs, founded the investigational research for adipose derived cell therapies at the Center for Regenerative Cell Medicine, and served as medical director for adipose tissues services at Celebration Stem Cell Labs in Arizona.
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
GSK's meningitis vaccine candidate accepted for FDA review
Innovent Biologics names new Oncology CMO
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
AbbVie announces interim evaluation of Atogepant Phase three, open-label 156-week extension study